目的:分析甘草大戟反药组合临床同用文献的文献特征。方法:系统检索十八反中甘草大戟组合同用的临床研究文献,从两者同用治疗疾病、用药剂量、配伍比例、给药剂型、给药途径及炮制入药情况等方面对两者临床同用文献的文献特征进行系统整理和分析。结果:临床共检索到甘草大戟组合同用文献36篇,有1篇文献文中提及不良事件情况。文献记载两者组合同用主要治疗中医内科的痰饮、臌胀、痹证等病,骨科主要治疗附骨疽。组合同用时两者多以“生甘草”“醋大戟”的炮制形式、以1:1的比例配伍使用,而且多以“汤剂”“口服”的形式使用。结论:临床确有甘草大戟组合同用的文献记载存在,但由于文献信息不足,无法进行定量疗效评价;而且由于文献提及不良事件观察的研究以及作者明确说明反药同用理论的研究均太少,仅有1篇文章记载不良事件且尚不能从文中判断是否是反药组合同用的原因所引起,所以甘草大戟反药同用的安全性尚不能确定。
Objective: To approach the applied condition of Gancao and Daji using together in clinical. Methods: According to the special search conditions to search the clinical literature of Gancao and Daji using together, to analyze these literature from the diseases, the dosage, the compatibility proportion, the dosage forms, the administration route and the processing drug conditions. Results: In clinical, Gancao and Dajii using together mainly to treat the diseases of traditional Chinese internal Medicine. Especially the phlegm retention, drum belly and pyogenic infection of bone, other department's record is lesser. When using together, they mostly use 'ShengGancao', 'CuDajii'; use the ratio of 1:1 and also be processed into decoction for oral use. In the 4 pieces literature which giving the adverse event, 3 pieces shows the two herbs could be used together. Conclusion: In clinical, It's really have the literature to record the two herbs using together, and some even show the combination have the good curative effect. Although this condition, whether the two herbs, even the eighteen incompatible herbs, can be used together in clinical, It's also need the deeply theoretical and experimental research.